Efficacy and safety of orismilast, a potent PDE4B/D inhibitor, in adults with moderate-to-severe atopic dermatitis: a phase 2b randomized, double-blind, placebo-controlled clinical trial (ADESOS)

Authors
Category Primary study
JournalBRITISH JOURNAL OF DERMATOLOGY
Year 2024
This article has no abstract
Epistemonikos ID: e89b909855e861e2f08522369f842db312906e20
First added on: Feb 18, 2025